CHAMPIONS ONCOLOGY, INC.
For the period ended Apr 30, 2026. Filed Jul 27, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Jul 27, 2026
CSBR$4.84+1.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
AS OF APRIL 30
(In Thousands except for shares)
| 2026 | 2025 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash | $4,872 | $9,785 |
| Accounts receivable, net | 13,178 | 11,204 |
| Prepaid expenses and other current assets | 1,169 | 1,369 |
| Total current assets | 19,219 | 22,358 |
| Operating lease right-of-use assets, net | 3,697 | 5,080 |
| Property and equipment, net | 3,526 | 4,375 |
| Other long term assets | 212 | 196 |
| Goodwill | 335 | 335 |
| Total assets | $26,989 | $32,344 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $6,903 | $4,248 |
| Accrued liabilities | 2,592 | 2,556 |
| Current portion of operating lease liabilities | 1,520 | 1,471 |
| Other current liabilities | 79 | 135 |
| Deferred revenue | 8,828 | 15,443 |
| Total current liabilities | 19,922 | 23,853 |
| Non-current portion operating lease liabilities | 2,992 | 4,634 |
| Other non-current liabilities | 7 | 85 |
| Total liabilities | $22,921 | $28,572 |
| Stockholders' equity: | ||
| Common stock, $.001 par value; 200,000,000 shares authorized; 14,007,159 and 13,897,503 shares issued; and 13,886,826 and 13,777,170 shares outstanding at April 30, 2026 and 2025, respectively | 14 | 14 |
| Treasury Stock, at cost | (708) | (708) |
| Additional paid-in capital | 85,700 | 84,358 |
| Accumulated deficit | (81,067) | (79,892) |
| Total stockholders’ equity attributable to Champions Oncology, Inc. | 3,939 | 3,772 |
| Noncontrolling interest | 129 | — |
| Total stockholders' equity | 4,068 | 3,772 |
| Total liabilities and stockholders' equity | $26,989 | 32,344 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.